Ras, PI(3)K and mTOR signalling controls tumour cell growth
about
Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapyThe regulation of cyclin D1 degradation: roles in cancer development and the potential for therapeutic inventionPI3K/AKT/mTOR inhibitors for advanced or recurrent endometrial cancerMolecular-targeted therapy for advanced gastric cancerPHLPP-mediated dephosphorylation of S6K1 inhibits protein translation and cell growthDirect association of Sprouty-related protein with an EVH1 domain (SPRED) 1 or SPRED2 with DYRK1A modifies substrate/kinase interactionsPhosphofructokinase 1 glycosylation regulates cell growth and metabolismSecond AKT: the rise of SGK in cancer signallingInteractome mapping of the phosphatidylinositol 3-kinase-mammalian target of rapamycin pathway identifies deformed epidermal autoregulatory factor-1 as a new glycogen synthase kinase-3 interactorShould individual PI3 kinase isoforms be targeted in cancer?EphA2 mediates ligand-dependent inhibition and ligand-independent promotion of cell migration and invasion via a reciprocal regulatory loop with AktAMPK phosphorylation of raptor mediates a metabolic checkpointCD164 regulates the tumorigenesis of ovarian surface epithelial cells through the SDF-1α/CXCR4 axisMammalian target of rapamycin: a central node of complex signaling cascadesThe mTOR signalling pathway in human cancerThe PI3K pathway as drug target in human cancerDelta-tocotrienol protects mouse and human hematopoietic progenitors from gamma-irradiation through extracellular signal-regulated kinase/mammalian target of rapamycin signalingPerifosine inhibits mammalian target of rapamycin signaling through facilitating degradation of major components in the mTOR axis and induces autophagyRoles of the Raf/MEK/ERK pathway in cell growth, malignant transformation and drug resistanceMolecular-targeted first-line therapy for advanced gastric cancerMetabolic Imaging to Assess Treatment Response to Cytotoxic and Cytostatic AgentsIntrinsic and Tumor Microenvironment-Induced Metabolism Adaptations of T Cells and Impact on Their Differentiation and FunctionMedical treatment for gastro-entero-pancreatic neuroendocrine tumoursPharmacodynamic Biomarker Development for PI3K Pathway TherapeuticsPotential role for mammalian target of rapamycin inhibitors as first-line therapy in hormone receptor-positive advanced breast cancerCancer Metabolism and Drug ResistanceMolecular Targeting of ERKs/RSK2 Signaling Axis in Cancer PreventionAmino acid management in cancerSplicing Regulators and Their Roles in Cancer Biology and TherapyNew and emerging factors in tumorigenesis: an overviewTargeting the PI3K/AKT/mTOR signaling axis in children with hematologic malignanciesIs cancer a metabolic disease?Coordination of nutrient availability and utilization by MAX- and MLX-centered transcription networksmTOR-dependent cell survival mechanismsAutophagy in malignant transformation and cancer progressionRegulation of the Ras-MAPK and PI3K-mTOR Signalling Pathways by Alternative Splicing in CancerCancer prevention with promising natural products: mechanisms of action and molecular targetsUse of mTOR inhibitors in the treatment of breast cancer: an evaluation of factors that influence patient outcomesWill kinase inhibitors make it as glioblastoma drugs?Small molecule compounds targeting the p53 pathway: are we finally making progress?
P2860
Q21198871-3825169A-D421-4233-90E1-E9B629EFC342Q21245733-DD065440-33E2-401B-BFBE-7EA17E541DF7Q24185960-BB58E53E-A3F0-4740-A15D-AE9E72C2D36AQ24187006-9FFDC159-1810-4BDD-9115-0B8BCA5876C9Q24292938-25E75343-428A-4A40-B4B9-A341439FD547Q24297221-1BDC91CD-65ED-43F6-952B-34B5BC140680Q24297510-9FD8FCEB-3BC3-4ACA-A31A-E00461593720Q24301817-3692B65B-3CA6-4281-8D14-06BC0644F304Q24305619-0850ECBF-2E52-448E-B8EF-186A7FBF6FADQ24309044-6515C0C6-EBEA-45B2-8735-080B03B2B17FQ24310260-89BC48A0-A3D1-40ED-9DAC-A4000F004911Q24329244-12B50B90-B923-4E62-B924-4D754F93C2EEQ24337710-ABB625CA-4957-4753-93CE-EA4D847F5A20Q24601702-76C00792-56CB-4EFE-945B-DAAB8BDFC86EQ24627306-7D638B0D-1476-4932-848B-FD2F97E72F88Q24632283-DADF0CAC-BE4C-4A2B-8CE8-585AEAB619E5Q24632362-A25452D1-9B6F-4B28-BDE2-0B966A8BF718Q24645466-41FA98A5-8938-42E0-B336-EC8C607EBA50Q24645668-F13E8DEF-D763-4353-B0F8-123CAE9F94C6Q26471049-961B12E5-FD87-442C-9B9B-591DE59FF0D4Q26740567-1C4CDA80-42D3-4552-BD09-FC3B7CA951AEQ26749556-C24D3361-7851-43BD-B64C-98C4D24FF096Q26751659-DBB639D6-70B7-4475-ACBC-2B5BE75A4430Q26766292-A4B12308-6194-4A4D-91F9-DD799D1F2C6AQ26775361-B7610698-64BB-4DDD-B4CC-BCA2DB796D0CQ26782042-7AEF241E-87DC-449B-9F55-31442C56606BQ26782527-766BA33B-43E3-4E16-9E50-4A5B93FB5A67Q26798087-655AE726-5022-4EF0-97C6-1B8296CEDC38Q26798158-AD8C54D8-2ED5-490F-B3F5-A6A0232E31C0Q26801253-F55437AE-8AEC-4574-BB52-487674038F4FQ26829652-2E58A942-3FDB-413E-BDF7-F801483154C3Q26852241-521DDA54-9828-439C-8185-F1369EE0DC06Q26853482-760165C0-8A49-47D8-8180-02E8ECBA1441Q26864688-B1713E0F-B473-448B-81E9-E8605CB5F77EQ27000191-27D40C74-1CBD-4BCB-A068-955381C91258Q27001635-A0E3F9AB-DE78-43B7-8DEF-4077E91D94BEQ27006530-1056D50F-8374-403A-A111-254B972C7B94Q27009257-C367B47D-C764-49C5-A559-C7389824FC1BQ27012684-0F683044-13D8-445E-ADC5-757B441BCAD0Q27027835-41ADE329-1BBD-44A6-9EAF-B4608909F865
P2860
Ras, PI(3)K and mTOR signalling controls tumour cell growth
description
2006 nî lūn-bûn
@nan
2006 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Ras, PI(3)K and mTOR signalling controls tumour cell growth
@ast
Ras, PI(3)K and mTOR signalling controls tumour cell growth
@en
type
label
Ras, PI(3)K and mTOR signalling controls tumour cell growth
@ast
Ras, PI(3)K and mTOR signalling controls tumour cell growth
@en
prefLabel
Ras, PI(3)K and mTOR signalling controls tumour cell growth
@ast
Ras, PI(3)K and mTOR signalling controls tumour cell growth
@en
P3181
P356
P1433
P1476
Ras, PI(3)K and mTOR signalling controls tumour cell growth
@en
P2093
P2888
P304
P3181
P356
10.1038/NATURE04869
P407
P577
2006-05-25T00:00:00Z
P5875
P6179
1031370745